Hybrid Analogues of Hydrazone and Phthalimide: Design, Synthesis, In vivo, In vitro, and In silico Evaluation as Analgesic Agents. 2024

Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
Department of Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Tehran Islamic Azad Medical Sciences University, Tehran, Iran.

BACKGROUND Based on the anti-inflammatory and analgesic activity of hydrazone and phthalimide, a new series of hybrid hydrazone and phthalimide pharmacophores was prepared and evaluated as analgesic agents. METHODS The designed ligands were synthesized by reaction of the appropriate aldehydes and 2- aminophthalimide. Analgesic, cyclooxygenase inhibitory, and cytostatic activity of prepared compounds were measured. RESULTS All the tested ligands demonstrated significant analgesic activity. Moreover, compounds 3i and 3h were the most potent ligands in the formalin and writhing tests, respectively. Compounds 3g, 3j, and 3l were the most COX-2 selective ligands and ligand 3e was the most potent COX inhibitor with a 0.79 of COX-2 selectivity ratio. The presence of electron-withdrawing moieties with hydrogen bonding ability at the meta position was found to affect the selectivity efficiently, in which compounds 3g, 3l, and 3k showed high COX-2 selectivity, and compound 3k was the most potent one. The cytostatic activity of selected ligands demonstrated that compounds 3e, 3f, 3h, 3k, and 3m showed good analgesic and COX inhibitory activity and were less toxic than the reference drug. CONCLUSIONS High therapeutic index of these ligands is one of the valuable advantages of these compounds.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008297 Male Males
D010146 Pain An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. Suffering, Physical,Ache,Pain, Burning,Pain, Crushing,Pain, Migratory,Pain, Radiating,Pain, Splitting,Aches,Burning Pain,Burning Pains,Crushing Pain,Crushing Pains,Migratory Pain,Migratory Pains,Pains, Burning,Pains, Crushing,Pains, Migratory,Pains, Radiating,Pains, Splitting,Physical Suffering,Physical Sufferings,Radiating Pain,Radiating Pains,Splitting Pain,Splitting Pains,Sufferings, Physical
D010797 Phthalimides The imide of phthalic acids.
D003198 Computer Simulation Computer-based representation of physical systems and phenomena such as chemical processes. Computational Modeling,Computational Modelling,Computer Models,In silico Modeling,In silico Models,In silico Simulation,Models, Computer,Computerized Models,Computer Model,Computer Simulations,Computerized Model,In silico Model,Model, Computer,Model, Computerized,Model, In silico,Modeling, Computational,Modeling, In silico,Modelling, Computational,Simulation, Computer,Simulation, In silico,Simulations, Computer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006835 Hydrazones Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed) Hydrazone
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
October 2019, Bioorganic chemistry,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
February 2016, Archives of pharmacal research,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
June 2022, Computational biology and chemistry,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
September 2010, Medicinal chemistry (Shariqah (United Arab Emirates)),
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
March 2019, Chemical biology & drug design,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
September 2015, Molecules (Basel, Switzerland),
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
August 2018, Bioorganic chemistry,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
December 2014, Archiv der Pharmazie,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
May 2021, Archiv der Pharmazie,
Shahla Shokri, and Hoda Ayazi, and Mohsen Tamjid, and Fatemeh Ghoreishi, and Mahsa Shokri, and Sogol Badakhshannouri, and Nima Naderi, and Bahram Daraei, and Zahra Mousavi, and Asghar Davood
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!